Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial
Alex Luedtke, Youyi Fong, Lars van der Laan, Fei Heng et autres
1 citationiScience
Jerald Sadoff
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
259Publications signalées
25111Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
SARS-CoV-2 and COVID-19 ResearchEscherichia coli research studiesCOVID-19 Clinical Research StudiesTuberculosis Research and EpidemiologyImmune responses and vaccinations
Publications récentes
Corrigendum to ‘Immune correlates analysis of the Imbokodo (HVTN 705/HPX2008) efficacy trial of a mosaic HIV-1 vaccine regimen evaluated in Southern African people assigned female sex at birth: a two-phase case-control study’. EBioMedicine 2024;108: 105320
Avi Kenny, Janine van Duijn, One Dintwe, Jack Heptinstall et autres
0 citationsEBioMedicine
Vaccine-induced T cell responses correlate with reduced risk of severe COVID-19 in a placebo-controlled efficacy trial
Nina Hertoghs, Sanne Roels, Matthias Brückner, Jerald Sadoff et autres
9 citationsEBioMedicine
Evaluating the Test-Negative Design for COVID-19 Vaccine Effectiveness Using Randomized Trial Data
Leah Andrews, M. Elizabeth Halloran, Lars van der Laan, Yunda Huang et autres
6 citationsJAMA Network Open
Comparison of vaccine-induced immune thrombocytopenia and thrombosis cases following two adenovirus-vectored COVID-19 vaccines
Rian Van Rampelbergh, Sue Pavord, Luis Anaya-Velarde, Vitalija van Paassen et autres
5 citationsCommunications Medicine
COVID-19 vaccine efficacy in participants with weakened immune systems from four randomized-controlled trials
Lawrence Corey, Jessica Tuan, Ian Hirsch, Ana M. Ortega‐Villa et autres
0 citationsUNC Libraries
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trial
Lindsay N. Carpp, Ollivier Hyrien, Youyi Fong, David Benkeser et autres
22 citationsNature Communications
Ad26.COV2.S COVID-19 Vaccine Safety And Immunogenicity in Adolescents 16–17 Years of Age
Javier Ruiz‐Guiñazú, Mathieu Le Gars, Vicky Cárdenas, Nathalie Vaissière et autres
0 citationsJournal of the Pediatric Infectious Diseases Society
Assessment of antibodies against platelet factor 4 following vaccination with adenovirus type 26–vectored vaccines
Hendy Kristyanto, Leen Slaets, Esmée Braams, Ilse Scheys et autres
5 citationsJournal of Thrombosis and Haemostasis
Pre- and post-Ad26.COV2·S booster dose antibody levels predict COVID-19 disease risk
Sanne Roels, Matthias Brückner, Jerald Sadoff, Vicky Cárdenas et autres
0 citationsVaccine
Safety, reactogenicity, and immunogenicity of Ad26.COV2.S as homologous or heterologous COVID-19 booster vaccination: Results of a randomized, double-blind, phase 2 trial
Mathieu Le Gars, Jerald Sadoff, Vicky Cárdenas, Dirk Heerwegh et autres
6 citationsVaccine
Modifiers of COVID-19 vaccine efficacy: Results from four COVID-19 prevention network efficacy trials
Jacqueline M. Miller, Glenda Gray, COVID- Prevention Network CoVPN, Iksung Cho et autres
0 citationsCarolina Digital Repository (University of North Carolina at Chapel Hill)
BNTIC News n’est pas le producteur de ces données. Métadonnées interrogées à la demande auprès de OpenAlex (CC0). Sources et limites.